» Articles » PMID: 37932331

Phage Therapy Minimally Affects the Water Microbiota in an Atlantic Salmon (Salmo Salar) Rearing System While Still Preventing Infection

Overview
Journal Sci Rep
Specialty Science
Date 2023 Nov 6
PMID 37932331
Authors
Affiliations
Soon will be listed here.
Abstract

Excessive usage of antibiotics threatens the bacterial diversity in the microbiota of animals. An alternative to antibiotics that has been suggested to not disturb the microbiota is (bacterio)phage therapy. In this study, we challenged germ-free and microbially colonized yolk sac fry of Atlantic salmon with Flavobacterium columnare and observed that the mere presence of a microbiota protected the fish against lethal infection. We then investigated the effect of phage- or oxytetracycline treatment on fish survival and rearing water bacterial community characteristics using 16S rRNA gene amplicon sequencing. Phage treatment led to an increased survival of F. columnare-challenged fish and reduced the relative amounts of the pathogen in the water microbiota. In the absence of F. columnare, phage treatment did not affect the composition or the α-diversity of the rearing water microbiota. In the presence of the phage's host, phage treatment induced minor changes to the bacterial community composition, without affecting the α-diversity. Surprisingly, oxytetracycline treatment had no observable effect on the water microbiota and did not reduce the relative abundance of F. columnare in the water. In conclusion, we showed that phage treatment prevents mortality while not negatively affecting the rearing water microbiota, thus suggesting that phage treatment may be a suitable alternative to antibiotics. We also demonstrated a protective effect of the microbiota in Atlantic salmon yolk sac fry.

Citing Articles

Optimized Dosing and Delivery of Bacteriophage Therapy for Wound Infections.

Lin Y, Dharmaraj T, Chen Q, Echterhof A, Manasherob R, Zhang L bioRxiv. 2024; .

PMID: 38766200 PMC: 11100690. DOI: 10.1101/2024.05.07.593005.


Gliding motility proteins GldJ and SprB contribute to virulence.

Thunes N, Evenhuis J, Lipscomb R, Perez-Pascual D, Stevick R, Birkett C J Bacteriol. 2024; 206(4):e0006824.

PMID: 38517170 PMC: 11025331. DOI: 10.1128/jb.00068-24.

References
1.
Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, Horn M . Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies. Nucleic Acids Res. 2012; 41(1):e1. PMC: 3592464. DOI: 10.1093/nar/gks808. View

2.
Declercq A, Haesebrouck F, Van Den Broeck W, Bossier P, Decostere A . Columnaris disease in fish: a review with emphasis on bacterium-host interactions. Vet Res. 2013; 44:27. PMC: 3648355. DOI: 10.1186/1297-9716-44-27. View

3.
Loc-Carrillo C, Abedon S . Pros and cons of phage therapy. Bacteriophage. 2012; 1(2):111-114. PMC: 3278648. DOI: 10.4161/bact.1.2.14590. View

4.
Donati V, Madsen L, Middelboe M, Strube M, Dalsgaard I . The Gut Microbiota of Healthy and -Infected Rainbow Trout Fry Is Shaped by Antibiotics and Phage Therapies. Front Microbiol. 2022; 13:771296. PMC: 9128845. DOI: 10.3389/fmicb.2022.771296. View

5.
Pereira C, Silva Y, Santos A, Cunha A, Gomes N, Almeida A . Bacteriophages with potential for inactivation of fish pathogenic bacteria: survival, host specificity and effect on bacterial community structure. Mar Drugs. 2011; 9(11):2236-2255. PMC: 3229233. DOI: 10.3390/md9112236. View